These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 18451756

  • 1. Syncope after vaccination--United States, January 2005-July 2007.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2008 May 02; 57(17):457-60. PubMed ID: 18451756
    [Abstract] [Full Text] [Related]

  • 2. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases.
    Pediatrics; 2006 Mar 02; 117(3):965-78. PubMed ID: 16382131
    [Abstract] [Full Text] [Related]

  • 3. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, Brown KH, Mijalski CM, Tiwari T, Weston EJ, Cohn AC, Srivastava PU, Moran JS, Schwartz B, Murphy TV, Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 2006 Mar 24; 55(RR-3):1-34. PubMed ID: 16557217
    [Abstract] [Full Text] [Related]

  • 4. Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June-July 2005.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2005 Oct 14; 54(40):1023-5. PubMed ID: 16224452
    [Abstract] [Full Text] [Related]

  • 5. Vaccination coverage among adolescents aged 13-17 years - United States, 2007.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2008 Oct 10; 57(40):1100-3. PubMed ID: 18846032
    [Abstract] [Full Text] [Related]

  • 6. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS, Braun MM, Chen RT.
    MMWR Surveill Summ; 2003 Jan 24; 52(1):1-24. PubMed ID: 12825543
    [Abstract] [Full Text] [Related]

  • 7. Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June 2005-September 2006.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2006 Oct 20; 55(41):1120-4. PubMed ID: 17060898
    [Abstract] [Full Text] [Related]

  • 8. Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2010.
    Moro PL, Yue X, Lewis P, Haber P, Broder K.
    Vaccine; 2011 Nov 21; 29(50):9404-8. PubMed ID: 21920404
    [Abstract] [Full Text] [Related]

  • 9. Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents.
    Jackson LA, Baxter R, Reisinger K, Karsten A, Shah J, Bedell L, Dull PM, V59P13 Study Group.
    Clin Infect Dis; 2009 Jul 01; 49(1):e1-10. PubMed ID: 19476428
    [Abstract] [Full Text] [Related]

  • 10. FDA approval of expanded age indication for a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 Apr 17; 58(14):374-5. PubMed ID: 19373199
    [Abstract] [Full Text] [Related]

  • 11. The preteen visit: an opportunity for prevention.
    Campos-Outcalt D.
    J Fam Pract; 2006 Dec 17; 55(12):1054-6. PubMed ID: 17137541
    [Abstract] [Full Text] [Related]

  • 12. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003.
    McMahon AW, Iskander J, Haber P, Chang S, Woo EJ, Braun MM, Ball R.
    Pediatrics; 2005 Feb 17; 115(2):453-60. PubMed ID: 15687455
    [Abstract] [Full Text] [Related]

  • 13. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2010 May 28; 59(20):626-9. PubMed ID: 20508593
    [Abstract] [Full Text] [Related]

  • 14. FDA approval of expanded age indication for a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2011 Sep 23; 60(37):1279-80. PubMed ID: 21937974
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity and reactogenicity of co-administered tetanus-diphtheria-acellular pertussis (Tdap) and tetravalent meningococcal conjugate (MCV4) vaccines compared to their separate administration.
    Weston WM, Friedland LR, Wu X, Howe B.
    Vaccine; 2011 Jan 29; 29(5):1017-22. PubMed ID: 21134450
    [Abstract] [Full Text] [Related]

  • 16. U.S. Postlicensure safety surveillance for adolescent and adult tetanus, diphtheria and acellular pertussis vaccines: 2005-2007.
    Chang S, O'Connor PM, Slade BA, Woo EJ.
    Vaccine; 2013 Feb 27; 31(10):1447-52. PubMed ID: 23142308
    [Abstract] [Full Text] [Related]

  • 17. Use of MenACWY-CRM in adolescents in the United States.
    Black S, Block SL.
    J Adolesc Health; 2013 Mar 27; 52(3):271-7. PubMed ID: 23299001
    [Abstract] [Full Text] [Related]

  • 18. National vaccination coverage among adolescents aged 13-17 years--United States, 2006.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2007 Aug 31; 56(34):885-8. PubMed ID: 17728694
    [Abstract] [Full Text] [Related]

  • 19. Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 Sep 25; 58(37):1042-3. PubMed ID: 19779400
    [Abstract] [Full Text] [Related]

  • 20. National and state vaccination coverage among adolescents aged 13-17 years--United States, 2011.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2012 Aug 31; 61(34):671-7. PubMed ID: 22932301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.